- Home
- RMBL vs MCRB Comparison
RMBL vs MCRB Comparison
Compare RMBL & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMBL
- MCRB
- Stock Information
- Founded
- RMBL 2013
- MCRB 2010
- Country
- RMBL United States
- MCRB United States
- Employees
- RMBL N/A
- MCRB N/A
- Industry
- RMBL EDP Services
- MCRB Biotechnology: Pharmaceutical Preparations
- Sector
- RMBL Technology
- MCRB Health Care
- Exchange
- RMBL Nasdaq
- MCRB Nasdaq
- Market Cap
- RMBL 90.1M
- MCRB 72.4M
- IPO Year
- RMBL N/A
- MCRB 2015
- Fundamental
- Price
- RMBL $2.23
- MCRB $7.46
- Analyst Decision
- RMBL Hold
- MCRB Hold
- Analyst Count
- RMBL 4
- MCRB 5
- Target Price
- RMBL $4.50
- MCRB $73.67
- AVG Volume (30 Days)
- RMBL 112.8K
- MCRB 151.8K
- Earning Date
- RMBL 05-07-2025
- MCRB 05-07-2025
- Dividend Yield
- RMBL N/A
- MCRB N/A
- EPS Growth
- RMBL N/A
- MCRB N/A
- EPS
- RMBL N/A
- MCRB 8.98
- Revenue
- RMBL $1,146,100,000.00
- MCRB N/A
- Revenue This Year
- RMBL N/A
- MCRB N/A
- Revenue Next Year
- RMBL $8.46
- MCRB N/A
- P/E Ratio
- RMBL N/A
- MCRB $0.89
- Revenue Growth
- RMBL N/A
- MCRB N/A
- 52 Week Low
- RMBL $1.95
- MCRB $7.18
- 52 Week High
- RMBL $7.06
- MCRB $30.60
- Technical
- Relative Strength Index (RSI)
- RMBL 39.95
- MCRB 39.45
- Support Level
- RMBL $2.06
- MCRB $6.53
- Resistance Level
- RMBL $2.68
- MCRB $7.69
- Average True Range (ATR)
- RMBL 0.22
- MCRB 0.75
- MACD
- RMBL 0.01
- MCRB 0.03
- Stochastic Oscillator
- RMBL 21.79
- MCRB 25.91
About RMBL RumbleOn Inc. Class B
RumbleON Inc is a USA-based online retailer that allows both consumers and dealers to Buy-Sell-Trade-Finance pre-owned motorcycles in an efficient, fast, transparent, and engaging experience. Its segments include powersports dealership group and vehicle transportation services. The powersports dealership group segment is comprised of powersports dealerships that sell new and pre-owned powersports vehicles; parts, service and accessories; and finance and inventory products for powersports vehicles sold. The vehicle transportation services segment provides nationwide transportation brokerage services between dealerships and auctions.
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.